Our study shows that GEN treatment inhibits cytoplasmic translocation of Bcl-xL in NSCLC cells, and the level of cytoplasmic Bcl-xL was negatively correlated with radiosensitivity in NSCLC. The gene discussed is BCL2L1; the disease is non-small cell lung carcinoma.